HYBRID EVENT: You can participate in person at London or Virtually from your home or work.
Neonatal Tumours

Neonatal Tumours, a rare subset of Paediatric oncology, encompass a heterogeneous group of abnormal cell growths that manifest within the first 28 days of life. This intricate and challenging medical landscape presents a complex amalgamation of benign and malignant neoplasms affecting various organ systems, including the central nervous system, kidneys, liver, and soft tissues. Neonatal Tumours often pose unique diagnostic and therapeutic dilemmas due to their distinct biological characteristics and the delicate nature of the developing neonatal organism. Histological diversity further complicates the clinical picture, ranging from teratomas and neuroblastomas to rare entities such as congenital mesoblastic nephroma and infantile fibrosarcoma. Early detection and precise diagnosis are critical for developing effective treatment strategies, yet the intricate balance between therapeutic efficacy and potential harm to the vulnerable neonate demands a multidisciplinary approach. Advances in imaging modalities, molecular diagnostics, and genetic profiling have augmented our understanding of neonatal Tumours, enabling tailored therapeutic interventions. However, the limited pool of clinical data and the scarcity of large-scale trials dedicated to neonates pose formidable challenges for evidence-based management. Collaborative efforts among Paediatric oncologists, neonatologists, surgeons, and geneticists are imperative to navigate this intricate terrain, fostering a comprehensive understanding of neonatal Tumours and advancing therapeutic modalities to improve outcomes for these youngest and most fragile patients. As the medical community strives to unravel the intricacies of neonatal Tumours, the pursuit of innovative therapies and a nuanced understanding of the intricate interplay between molecular biology and clinical manifestations remain pivotal in optimizing the care and prognosis of neonates facing these formidable challenges.

Committee Members
Speaker at Pediatrics and Neonatology 2025 - Steven M Donn

Steven M Donn

University of Michigan, United States
Speaker at Pediatrics and Neonatology 2025 - Peter Averkiou

Peter Averkiou

Florida Atlantic University, United States
Speaker at Pediatrics and Neonatology 2025 - Catherine Fallet Bianco

Catherine Fallet Bianco

Sainte-Justine University Hospital, Canada
Speaker at Pediatrics and Neonatology 2025 - Jeanne Magagna

Jeanne Magagna

Great Ormond Street Hospital for Children, United Kingdom
EPN 2025 Speakers
Speaker at Pediatrics and Neonatology 2025 - Ann L Smith

Ann L Smith

Novant Health Forsyth Medical Center, United States
Speaker at Pediatrics and Neonatology 2025 - Tehreem Fatima

Tehreem Fatima

University of Connecticut, United States
Speaker at Pediatrics and Neonatology 2025 - Rohit Kumar

Rohit Kumar

James Cook Hospital, United Kingdom
Speaker at Pediatrics and Neonatology 2025 - Nicola Webster

Nicola Webster

North West Regional Hospital, Australia
Speaker at Pediatrics and Neonatology 2025 - Tadel Karolina

Tadel Karolina

Wroclaw Medical University, Poland
Speaker at Pediatrics and Neonatology 2025 - Vlad Dima

Vlad Dima

Filantropia Clinical Hospital, Romania

Submit your abstract Today

Watsapp